Cargando…

A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis

Detalles Bibliográficos
Autores principales:	Liu, Mingsheng, Yao, Xiaoli, Huang, Xusheng, Shang, Huifang, Fan, Dongsheng, He, Jia, Cui, Liying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106172/ https://www.ncbi.nlm.nih.gov/pubmed/36805548 http://dx.doi.org/10.1097/CM9.0000000000002442

Ejemplares similares

Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023)

Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
por: Mandrioli, Jessica, et al.
Publicado: (2023)

Lack of association of TP73 rare variants with amyotrophic lateral sclerosis in a Chinese cohort
por: Li, Chunyu, et al.
Publicado: (2022)

DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study
por: Chen, Dawei, et al.
Publicado: (2020)

A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
por: Dupuis, Luc, et al.
Publicado: (2012)

Neurophysiological Differences between Flail Arm Syndrome and Amyotrophic Lateral Sclerosis
por: Yang, Hecheng, et al.
Publicado: (2015)

Cognitive Impairment in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis
por: Cui, Bo, et al.
Publicado: (2015)

Differences in Dysfunction of Thenar and Hypothenar Motoneurons in Amyotrophic Lateral Sclerosis
por: Fang, Jia, et al.
Publicado: (2016)

“Huoling Shengji granule” for amyotrophic lateral sclerosis: protocol for a multicenter, randomized, double-blind, riluzole parallel controlled clinical trial
por: Liu, Xiaolu, et al.
Publicado: (2023)

Anesthetic management of a parturient with amyotrophic lateral sclerosis undergoing cesarean section
por: Li, Jiao, et al.
Publicado: (2020)

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
por: Lauria, Giuseppe, et al.
Publicado: (2015)

Epigenome-wide DNA methylation study of whole blood in patients with sporadic amyotrophic lateral sclerosis
por: Cai, Zhengyi, et al.
Publicado: (2022)

Protective effects of dl-3n-butylphthalide against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2013)

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
por: Chen, Yajing, et al.
Publicado: (2019)

Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
por: Mandrioli, Jessica, et al.
Publicado: (2018)

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
por: Al-Chalabi, Ammar, et al.
Publicado: (2019)

Restless Legs Syndrome in Chinese Patients With Sporadic Amyotrophic Lateral Sclerosis
por: Liu, Shuangwu, et al.
Publicado: (2018)

Split-Hand Syndrome in Amyotrophic Lateral Sclerosis: Differences in Dysfunction of the FDI and ADM Spinal Motoneurons
por: Wang, Zhi-Li, et al.
Publicado: (2019)

A Retrospective Study of the Characteristics and Clinical Significance of A-Waves in Amyotrophic Lateral Sclerosis
por: Fang, Jia, et al.
Publicado: (2017)

Repetitive nerve stimulation on survival in amyotrophic lateral sclerosis
por: Zhu, Yahui, et al.
Publicado: (2023)

Dl-3-n-butylphthalide regulates cholinergic dysfunction in chronic cerebral hypoperfusion rats
por: Sun, Yanan, et al.
Publicado: (2020)

Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
por: Chen, Yajing, et al.
Publicado: (2021)

Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients
por: Chen, Xueping, et al.
Publicado: (2018)

Granulocyte Colony-Stimulating Factor for Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study of Iranian Patients
por: Amirzagar, Nasibeh, et al.
Publicado: (2015)

Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
por: Beghi, Ettore, et al.
Publicado: (2022)

Mutation spectrum of chinese amyotrophic lateral sclerosis patients with frontotemporal dementia
por: Yang, Xunzhe, et al.
Publicado: (2022)

Differences in F-Wave Characteristics between Spinobulbar Muscular Atrophy and Amyotrophic Lateral Sclerosis
por: Fang, Jia, et al.
Publicado: (2016)

Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis
por: Cheng, Yangfan, et al.
Publicado: (2021)

Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study
por: Li, Da-Wei, et al.
Publicado: (2018)

Correlation of Creatine Kinase Levels with Clinical Features and Survival in Amyotrophic Lateral Sclerosis
por: Tai, Hongfei, et al.
Publicado: (2017)

Eye Movement Abnormalities in Amyotrophic Lateral Sclerosis
por: Guo, Xintong, et al.
Publicado: (2022)

The Gold Coast criteria increases the diagnostic sensitivity for amyotrophic lateral sclerosis in a Chinese population
por: Shen, Dongchao, et al.
Publicado: (2021)

Lipid Profile in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
por: Liu, Jiao, et al.
Publicado: (2020)

Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial
Publicado: (2013)

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
por: Abe, Koji, et al.
Publicado: (2014)

Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis
por: Gu, Xiaojing, et al.
Publicado: (2021)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Prognostic Nomogram Associated with Longer Survival in Amyotrophic Lateral Sclerosis Patients
por: Wei, Qian-Qian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d1u80ju1j4jpif15cem1i42npi